Imaging in Local Staging of Gastric Cancer: A Systematic Review
- 20 May 2007
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (15), 2107-2116
- https://doi.org/10.1200/jco.2006.09.5224
Abstract
Purpose Endoscopic ultrasound (EUS) has been established as the diagnostic modality of choice in local (T) staging of gastric cancer. Multidetector row computed tomography (MDCT) and magnetic resonance imaging (MRI) are promising alternatives. The aim of this study was to systematically review the literature regarding the performance of each of these imaging modalities. Methods A systematic search for relevant studies was performed in the PubMed/MEDLINE and EMBASE databases. Two reviewers independently assessed the methodological quality of each study. Local staging performance of included studies was calculated. Results Twenty-two EUS studies, five MDCT studies, one combined EUS and MDCT study, and three MRI studies met the inclusion criteria. The studies were of moderate methodological quality. Diagnostic accuracy of overall T staging for EUS, MDCT, and MRI varied between 65% to 92.1%, 77.1% to 88.9%, and 71.4% to 82.6%, respectively. Sensitivity for assessing serosal involvement for EUS, MDCT, and MRI varied between 77.8% to 100%, 82.8% to 100%, and 89.5% to 93.1%, respectively. Specificity for assessing serosal involvement for EUS, MDCT, and MRI varied between 67.9% to 100%, 80% to 96.8%, and 91.4% to 100%, respectively. Conclusion EUS, MDCT, and MRI achieve similar results in terms of diagnostic accuracy in T staging and in assessing serosal involvement. Most experience has been gained with EUS. Few MDCT studies and even fewer MRI studies are available. Thus, EUS remains the first-choice imaging modality in preoperative T staging of gastric cancer.Keywords
This publication has 66 references indexed in Scilit:
- A phase II trial of neoadjuvant cisplatin–fluorouracil followed by postoperative intraperitoneal floxuridine–leucovorin in patients with locally advanced gastric cancerAnnals of Oncology, 2006
- Serosal involvement in gastrointestinal cancer: its assessment and significanceHistopathology, 2005
- Endoscopic ultrasonography: current clinical roleEuropean Journal of Gastroenterology & Hepatology, 2005
- International variationOncogene, 2004
- Surgical treatment and prognosis of gastric cancer in 2 613 patientsWorld Journal of Gastroenterology, 2004
- Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II studyGastric Cancer, 2003
- Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion.Oncology Reports, 2003
- Cancer burden in the year 2000. The global pictureEuropean Journal Of Cancer, 2001
- Long‐term Survival of Transmural Advanced Gastric Carcinoma following Curative Resection: Multivariate Analysis of Prognostic FactorsWorld Journal of Surgery, 2000
- Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancerBritish Journal of Surgery, 1990